Evidence map›Paper›PMID 41646662›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Feature Integration of [

Youjin Lee, Seonguk Kim, Sangil Kim, Yeona Kang, Alzheimer’s Disease Neuroimaging Initiative

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Youjin LeeDepartment of Mathematics, Pusan National University, Busan, Republic of Korea.
Seonguk KimDepartment of Mathematics, Defiance College, Defiance, Ohio, United States.
Sangil KimDepartment of Mathematics, Pusan National University, Busan, Republic of Korea.
Yeona KangDepartment of Mathematics, Howard University, Washington, D.C., United States.ORCID 0000-0003-3384-435X
Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Background: Distinguishing individuals with cognitive decline (CD), including early Alzheimer's disease, from cognitively normal (CN) individuals is essential for improving diagnostic accuracy and enabling timely intervention. Positron emission tomography (PET) captures functional brain alterations associated with CD, but its broader application is often limited by cost and radiation exposure. To enhance the clinical utility of PET while addressing data limitations, we propose a multi-representational learning framework that leverages both imaging data and region-level quantification in a data-efficient manner. Methods: Voxel-level features were extracted using convolutional neural networks (CNN) or principal component analysis networks (PCANet) from [¹⁸F]FDG PET imaging. Region-level features were derived from standardized uptake value ratio measurements across predefined brain regions and processed using a deep neural network (DNN). These voxel- and region-level information are integrated through direct concatenation. For final prediction, different machine learning models and ensemble technique were applied. The models were trained and validated using 5-fold cross-validation on PET scans from 252 participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI), comprising 118 CN and 134 CD subjects. Additional correlation analysis and disease classification comparison with the Mini-Mental State Examination (MMSE) were also performed. Results: In 5-fold cross-validation, CNN, PCANet, and DNN models achieved classification accuracies of 0.69 ± 0.04, 0.69 ± 0.06, and 0.82 ± 0.06, respectively. The integrated DNN-CNN model using direct concatenation yielded the highest accuracy (0.87 ± 0.05), with a 6.10% improvement in accuracy and reduced standard deviation relative to the DNN-only model. Moreover, there were an increase of 14.29% in Recall (0.77 to 0.88) and an increase of 7.32% in F1-Score (0.82 to 0.88). Moreover, the model output showed a significant level of relation with MMSE, and it outperformed the MMSE-based classification in accuracy, recall, and f1, except precision. Conclusion: Combining PET imaging with region-level quantification and deep learning improves diagnostic performance over single-feature based models. Notably, fusion-based approaches enhanced sensitivity to cognitive decline. This multimodal strategy offers a more data-efficient and accurate approach for classifying cognitive decline and supports broader PET application in clinical settings.

Identifiers

PMID41646662
PMCPMC12870617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.